Assessing the Diagnostic Accuracy of an On-line Questionnaire for Diagnosis of Primary Headache Disorders
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03304886 |
Recruitment Status :
Completed
First Posted : October 9, 2017
Last Update Posted : October 14, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Headache Disorders |
The worldwide current gold standard for diagnosing headaches is the International Classification of Headache Disorders (ICHD 3 beta). Adhering strictly to ICHD criteria has been problematic for accurately diagnosing patients in the clinic and as for clinical trials. To address these issues, an online instrument was developed that successfully diagnosis common primary and secondary headache disorders. In this research Investigator hopes to demonstrate an on- line questionnaire is non inferior to a semi-structured interview for accurately diagnosing different types of headaches (for example: episodic migraine vs. non episodic migraine, chronic migraine vs. non chronic migraine, episodic tension-type vs. non-episodic tension type, chronic tension-type headache vs. non chronic tension-type headache, medication overuse headache vs. non medication overuse headache, post traumatic headache vs. non post traumatic headache).
Participants will be screened by telephone to see if participants meet the criteria for taking part in this research study. Once participant is deemed eligible,the participants will then be randomized in a 1:1 ratio to complete either the semi-structured interview over the phone first and then complete the online questionnaire or vice versa. Study is expected to enroll 500 participants with headache and healthy controls.
Study Type : | Observational |
Actual Enrollment : | 250 participants |
Observational Model: | Case-Control |
Time Perspective: | Cross-Sectional |
Official Title: | Diagnostic Comparison of an Online Questionnaire Versus a Semi-structured Interview for the Diagnosis of Primary Headache Disorders, Using ICHD 3 as the Gold Standard |
Actual Study Start Date : | February 28, 2018 |
Actual Primary Completion Date : | October 30, 2019 |
Actual Study Completion Date : | December 30, 2019 |
Group/Cohort |
---|
Migraineurs
with a migraine
|
Control
Participants without migraine
|
- On-line questionnaire accuracy for Diagnosing episodic migraine [ Time Frame: 2 -2.5 years ]An on- line questionnaire is non inferior to a semi-structured interview for accurately diagnosing episodic migraine vs non episodic migraine, chronic migraine vs. non chronic migraine. We will compare the 4 primary (chronic and episodic migraine, chronic and episodic tension-type headache) obtained on each of the two evaluations for reliability using recognized statistical tools: This analysis will be conducted by independent reviewers, not the developers of either instrument

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 65 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- Female or male subjects age between age 18-65(inclusive),
- Subjects must agree to sign online informed consent;
- Subject must be able to understand and willing to complete both evaluations in English
- Willing to comply with study instructions.
- Agree not to Rely or act on any diagnosis given to them in the study
Exclusion Criteria:
1. Presence of Disorders listed in groups 5-13 of The International Headache Society Classification of Head and Facial Pain (Headache Classification Committee of the International Headache Society, 2015 except for post traumatic headache and medication overuse headache);
1a. History of brain tumor, brain surgery
1b. History of brain infection such as meningitis, encephalitis, or meningoencephalitis
1c. History of any significant current or previous brain dysfunction
1d. Regular use of illicit drugs.
2. Known significant medical or psychiatric disease or abnormal laboratory data that would preclude entry into this study.
3. Subjects with - significant cognitive impairment such as dementia, active psychiatric disease such as schizophrenia.
4. Subjects with physical limitations to participate in the on-line or phone interview impossible.
5. Non-English speaking patients

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03304886
United States, California | |
Stanford University, School of Medicine | |
Palo Alto, California, United States, 94304 |
Principal Investigator: | Robert Cowan, MD, FAAN | Stanford University |
Responsible Party: | Robert Cowan, Director and Chief, Division of Headache Medicine, Stanford University |
ClinicalTrials.gov Identifier: | NCT03304886 |
Other Study ID Numbers: |
John Henry study |
First Posted: | October 9, 2017 Key Record Dates |
Last Update Posted: | October 14, 2020 |
Last Verified: | October 2020 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Headache Disorders Headache Disorders, Primary Headache Pain |
Neurologic Manifestations Brain Diseases Central Nervous System Diseases Nervous System Diseases |